anonymous
Guest
anonymous
Guest
Riley, you’re dope.
Hi all, my name is Riley. I'm a pharma reporter for Bloomberg News who has been covering Insys' dwindling cash-flow since last December. If you'd like to share your experience at the drugmaker, I'm reachable at rgriffin42@bloomberg.net.